Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

UK Life Sciences Strategy - one year on

Genome diagnostic can see if a patient is ‘ageing well’

Test can predict risk of age-related diseases and age of death

- PMLiVE

Cancer Drugs Fund axes 16 treatments after overspending

Medicines from Roche, Celgene, Merck KGaA and Janssen among those dropped

- PMLiVE

First-ever World Hepatitis Summit calls for national programmes

Follows rise in hepatitis deaths for fifth consecutive year

- PMLiVE

NICE turns down Celgene’s Otezla once again

Concludes the drug's cost outweighs its benefit for psoriatic arthritis

Novartis day

Novartis’ Farydak gets nod for myeloma in Europe

HDAC inhibitor offers new mechanism of action in fight against myeloma

- PMLiVE

Novartis launches first biosimilar Zarxio in the US

Follows Amgen's failure to block Neupogen-version from release

- PMLiVE

Pharma perspectives: communications creativity (part 2)

David Higgins from Sudler & Hennessey Group on what it means to be creative in healthcare communications

- PMLiVE

Pharma perspectives: communications creativity (part 1)

AstraZeneca business unit director Samuel Hollis on what healthcare communications creativity means to him

- PMLiVE

Frontera supports unique fashion auction for homeless charity

Eventis part of the agency's pro-bono work for London-based Pathway

- PMLiVE

Health board game developed to educate the young

TheFood, Mood and Health Game aims to help broach difficult food-related topics 

- PMLiVE

Novartis’ heart failure drug approved via early access scheme

LCZ696 issued positive scientific opinion under EAMS

Cello Health BioConsulting appoints Jim Hall as president

Senior pharma marketer to preside over newly-formed consulting firm

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links